Prostate News Archive
31-Oct-2008
Statins Lower Blood Marker for Prostate Cancer (HealthDay via Yahoo! News)
THURSDAY, Oct. 30 (HealthDay News) -- A new study shows that men who take cholesterol-lowering drugs called statins have lower blood levels of prostate-specific antigen (PSA), a biomarker for prostate cancer risk. Prostate cancer: Selenium, vitamin E trial halted, statins lower marker, not necessarily risk (Scientific American)
Cholesterol-lowering statin drugs reduce levels of a blood marker for prostate cancer, but it's not clear they actually lower the risk of developing the disease. [More] Major Study of Supplements and Prostate Cancer Halted (American Cancer Society via Yahoo! News)
The National Cancer Institute has stopped a major clinical trial studying whether vitamin E and selenium can prevent prostate cancer because early analysis suggests the supplements don't work. What's more, there is some evidence that they may actually be harmful. Tracking down Pygopus: Researcher looking for a better way to tell if prostate cancer patients need hormone therapy (The Telegram)
A prostate cancer treatment that reduces male hormones in the body can save men?s lives and stop cancer growth, but it has plenty of known side-effects ? hot flashes, impotence, incontinence and osteoporosis.
Back to Prostate News Archive
